Elise A. Chong, MD

Adam Kittai, Paul Hampel, Ying Huang, John Allan, Seema Bhat, David Bond, Danielle Brander, John Byrd, Julio Chavez, Elise Chong, Alexey Danilov, Matthew Davids, Kaitlyn Dvorak-Kornaus, Hannah Freedman, Nikita Malakhov, Mathew Matasar, Cecelia Miller, Sarah Miller-Branam, Zulfa Omer, Sameer Parikh, Erin Parry, Kari Rabe, Philipp Raess, Manoj Rai, Joanna Rhodes, Kerry Rogers, Aditi Saha, Jake Schade, Geoffrey Shouse, Stephen Spurgeon, Deborah Stephens, Yucai Wang, Jennifer Woyach, Max Yano Hodgkin lymphoma transformation in patients with chemotherapy-naïve chronic lymphocytic leukemia , Blood Cancer Journal : 2026

Chong EA, Tomasulo EB, Barta SK. 2026 Update on the Management of Diffuse Large B-Cell Lymphoma , Am J Hematol, 101(4): 2026,832-863

Landsburg DJ, Musoke N, Gentile C, Brooks TR, Nasta SD, Barta SK, Carter JS, Chong EA, Svoboda J, Schuster SJ, Thomas CJ, Tomasulo EB, Cook MR, Morrissette JJD, Caimi PF, Hill BT. Prognostic impact of TP53 alterations in cases of newly diagnosed large B-cell lymphoma , Leukemia, 40(3): 2026,694-697

Jiang C, Hoover T, Baron J, Han X, Li B, Gao Y, Kim M, Hubbeling H, Chong EA, Carter J, Svoboda J, Schuster SJ, Landsburg DJ, Nasta SD, Plastaras J, LaRiviere M. Long Term Results of Proton Therapy in Adult Infradiaphragmatic Lymphoma. , Int J Part Ther, 19: 2026,101304

Shan Liu; Puneeth Guruprasad; Ranjani Ramasubramanian; Bhoomi Madhu; Luca Paruzzo; Kecheng Han; Andre Kelly; Alexander Shestov; He N Xu; Alberto Carturan; Chaoting Zhou; Kevin R Amses; Amichay Afriat; Lev Litichevskiy; Jason Lin; Ezra Dubowitz; Neil Tangal; Jing Zhang; Alana McSween; Melody Tan; Federico Stella; Andrew Lee; Siena Nason; Xianxin Hua; Michael Schneider; Madeleine Sleeman; Yunlin Zhang; Giulia Gabrielli; Ziqi Yang; Raymone Pajarillo; Ruchi Patel; Guido Ghilardi; Vrutti Patel; Akshita Joshi; Shunzhou Jiang; Yanqing Jiang; Patrizia Porazzi; Julia C Tchou; Brian Keith; Mingyao Li; Elise Chong; Stephen J Schuster; Michael Milone; Joshua Rabinowitz; Roderick O’Connor; Christoph A Thaiss; Maayan Levy; Marco Ruella β-Hydroxybutyrate Enhances the Metabolic Fitness of CAR T Cells in Cancer , Cell: 2026

Epstein-Peterson ZD, Lionel AC, Joseph A, Drill E, Atallah-Yunes SA, Brooks TR, Chong EA, Chong ER, Dela Cruz J, Frank MJ, Ip A, Iqbal M, Jacobson CA, Kamdar MK, Karmali R, Beyar-Katz O, Maddocks KJ, Matasar MJ, McLoughlin D, Merryman RW, Munoz JL, Navalekar R, Rhodes J, Riedell PA, Ryan CE, Salles G, Sauter CS, Sawalha Y, Sharma S, Shouval R, Shukla N, Therwhanger D, van Besien H, Varon B, Wang Y, Yamshon S, Zelenetz AD, Palomba ML, Jain P, Kumar A. Treatment and outcomes of progression of disease post-CAR T-cell therapy in mantle cell lymphoma: a multicenter analysis , Blood Adv, 9(21): 2025,5654-5662

Luke Maillie, Stefan Barta, Jordan Carter, Michael Cook, Mitchell Hughes, Daniel Landsburg, Sunita Dwivedy Nasta, Marco Ruella, Stephen Schuster, Jakub Svoboda, Colin Thomas, Emily Tomasulo, Elise Chong Frontline experience with second generation covalent Bruton tyrosine kinase inhibitors for mantle cell lymphoma: A single center experience , Blood, 146(Supplement 1): 2025,7119

Sagar Patel, Elise Chong, Farah Toron, Fei Fei Liu, Fangyi Gu, John Baird, Sameh Gaballa Real-world evaluation of health care resource utilization, clinical effectiveness, and safety of lisocabtagene maraleucel and axicabtagene ciloleucel administered in the outpatient (OP) setting for R/R large B-cell lymphoma (LBCL) , Blood, 146(Supplement 1): 2025,6270

Emeline Chong, Megan Jones, Guido Ghilardi, Luca Paruzzo, Sunita Dwivedy Nasta, Stefan Barta, Jakub Svoboda, Elise Chong, Jordan Carter, Colin Thomas, Michael Cook, Emily Tomasulo, Marco Ruella, Daniel Landsburg, Stephen Schuster Duration of lymphopenia after CAR-T cell therapy is associated with increased risk of non-melanoma skin cancers and decreased survival , Blood, 146(Supplement 1): 2025,3728

Michael Cook, Emeline Chong, Ava Clifford, Daniel Landsburg, Sunita Dwivedy Nasta, Elise Chong, Stefan Barta, Jakub Svoboda, Jordan Carter, Colin Thomas, Emily Tomasulo, Stephen Schuster Risk factors for failure to complete step-up-dosing of bispecific antibody therapy for B-cell lymphomas , Blood, 146(Supplement 1): 2025,5522